CyrusOne Announces Krupal Raval as new Chief Strategy Officer
CyrusOne, a leading global data center developer and operator, specializing in delivering state-of-the-art digital infrastructure solutions, today announced the addition of Krupal Raval to its Senior Management Team as Executive Vice President and Chief Strategy Officer. In this newly created role, Krupal will lead the company’s rapidly growing development program across the U.S. and drive strategic engagement with hyperscale customers.
“CyrusOne has a well-established reputation in the industry for execution and innovation, and I am thrilled to join such an experienced and capable team,” said Raval. “I am looking forward to leveraging my background to further the company’s vision and strategic goals.”
Before joining CyrusOne, Krupal served as Managing Director, xScale at Equinix where he led the hyperscale data center business, orchestrating multiple multi-billion-dollar joint ventures that shaped markets across the Americas, EMEA, and APAC. His strategic vision and execution capabilities previously drove growth as the Chief Financial Officer for Digital Realty's Asia Pacific operations.
“Krupal brings exceptional industry experience and proven leadership to CyrusOne," said Eric Schwartz, CEO of CyrusOne. "With more than a dozen new data centers under construction and an aggressive expansion pipeline, Krupal’s addition to our team – with his deep hyperscaler relationships and strategic vision – will be instrumental in accelerating our growth trajectory and strengthening our market position."
About CyrusOne
CyrusOne is a leading global data center owner, developer and operator, delivering sophisticated digital infrastructure solutions worldwide. Headquartered in Dallas, Texas, the company operates over 55 data centers across the United States, Europe, and Japan. Specializing in comprehensive solutions for hyperscale and enterprise companies, CyrusOne enables customers to align with their unique business and sustainability goals, catering to the complex needs of AI-driven applications and services workloads. CyrusOne’s data centers offer unparalleled flexibility, enabling customers to modernize, simplify, and rapidly respond to changing demands. CyrusOne delivers tailored build-to-suit, colocation, and interconnection solutions that meet the evolving digital needs of its customers. For more information, please visit cyrusone.com.
CyrusOne Forward Looking Statement
This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Forward-looking statements in this press release include, but are not limited to, statements that refer to future plans and expectations, projections of our future performance or operations, our anticipated growth and trends in our and our customers’ respective businesses, industries and geographical markets, and other characterizations of future events or circumstances, such as sites under development and construction. These statements are based on current expectations, estimates, forecasts, and projections about the industries and locations in which we and our customers operate and the beliefs and assumptions of our management as of the date of this press release. These statements are not guarantees of future performance and are subject to known and unknown risks and uncertainties. Actual results may vary materially and adversely from those expressed or implied in this press release. These statements are made as of the date of this press release and CyrusOne disclaims any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250602042074/en/
Contacts
press@cyrusone.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Partnership Between Onboard Dynamics and T.D. Williamson Aims to Reduce Pipeline Emissions Across Eastern Hemisphere5.6.2025 08:00:00 EEST | Press release
Onboard Dynamics LLC (“Onboard Dynamics”), a leading developer of pipeline evacuation technology, has entered into a strategic partnership with T.D. Williamson (“TDW”), a global provider of pipeline services and equipment. This collaboration will enable TDW to represent, market, and sell Onboard Dynamics’ products and services directly to customers across the Eastern Hemisphere through its own network of channel partners. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250604551886/en/ Onboard Dynamics’ GoVAC® Pipeline Evacuation System—an innovative, self-powered mobile unit designed to capture and recover natural gas during pipeline evacuations, eliminating the need for venting or flaring. Pictured here in action during a pipeline drawdown project in France. The partnership spans a broad and strategically important region—including Europe, Central Asia, the Middle East, Africa, India, and the Asia-Pacific—where the demand f
Special Seminar Paves the Way for European Dairy Brands to Enter China ’ s Special Food Market Under New Rules5.6.2025 05:50:00 EEST | Press release
CCIC Europe Food Test Co., Ltd. (CCIC EFT) is stepping up efforts to help more European companies access China’s infant formula market. On June 25–26, CCIC EFT will host a targeted seminar in Wageningen, the Netherlands, focused on regulatory updates and market access for producers of infant formula, older infant and toddler milk-based formula, and food for special medical purposes (FSMP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250604444992/en/ CCIC Europe Food Test Co., Ltd. (CCIC EFT) and Technology Innovation Center of Special Food, State Administration of Market Regulation (TISF, SAMR) in the Netherlands. Co-organized with the Technology Innovation Center of Special Food, State Administration of Market Regulation (TISF, SAMR), the seminar is designed for professionals familiar with Chinese regulations and seeking the latest updates on standards, product registration, and market trends. Attendees will benefit from
Belkin Unveils New Gaming Portfolio Featuring Power-Packed Charging Accessories and Gaming Essentials5.6.2025 02:00:00 EEST | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced its entry into the gaming accessories space with the launch of a new lineup designed to be compatible with the highly anticipated Nintendo Switch 2. Built on decades of experience in power, connectivity and device protection, and released under Belkin’s innovation-focused Future Ventures category, this marks the company’s first collection of products tailored specifically for the gaming community. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250604528148/en/ Belkin’s lineup of Nintendo Switch 2 accessories Belkin is “Leveling up your play” – bringing a new level of reliability to the gaming ecosystem that differentiates through premium materials, timeless design, and in-house engineering. The new range includes elevated accessories designed to enhance the Nintendo Switch 2 experience, featuring on-the-go charging solutions, audio gear, robust s
Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)5.6.2025 02:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) and Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (“NJCTTQ”) announced that NTB003 (formerly BCG009), a co-developed injectable drug candidate, has received the Investigational New Drug (IND) approval from the National Medical Products Administration (NMPA). The approved indication is Thyroid Eye Disease (TED). About NTB003 Injection NTB003 is a second-generation fully human anti-IGF-1R monoclonal antibody co-developed by Biocytogen and Nanjing Chia Tai Tianqing. Antibody discovery and optimization were completed by Biocytogen using its proprietary RenMab™ fully human antibody discovery platform, while Nanjing Chia Tai Tianqing was responsible for CMC process development, GLP-compliant toxicology studies, and IND application. Compared with first-generation approved anti-IGF-1R therapeutics, NTB003 demonstrates enhanced molecular affinity, improved druggability, and an extended half-life. In vitro studies ha
New Potential Treatment Strategy for Brain Metastases and Leptomeningeal Disease: HER3-DXd Shows Promising Results in the Phase II TUXEDO-3 Study for Patients With Limited Therapeutic Options4.6.2025 21:19:00 EEST | Press release
Leading international medical research company, MEDSIR announced today the positive results of the TUXEDO-3 trial at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025. This phase II study funded by Daiichi Sankyo and Merck, known as MSD outside of the United States and Canada, evaluates the efficacy and safety of patritumab deruxtecan (HER3-DXd) in patients with active brain metastases and leptomeningeal disease, serious complications associated with advanced stages of the cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250604087994/en/ Dr. Matthias Preusser during Oral Presentation of TUXEDO-3 at ASCO 2025 The study was carried out to evaluate HER3-DXd in patients with metastatic breast cancer (mBC) and advanced non-small cell lung cancer (aNSCLC) with active brain metastases, and patients with leptomeningeal disease from solid tumors. This is an antibody-drug conjugate to target HER3, a protein re
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom